The KDIGO Controversies Conference on Therapies Targeting B Cells in Immune-Mediated Kidney Diseases will gather a global multidisciplinary panel of nephrologists, rheumatologists, pathologists, immunologists, cell therapists, and patients to address the therapeutic strategy of targeting of B-cells for the management of autoimmune and immune-mediated kidney diseases.  The goal of this KDIGO conference is to review the efficacy and safety of B cell-targeted approaches directed at the underlying drivers of disease and to assess how they supplement or replace existing management paradigms.

 

Dr. Jürgen Floege (University of Aachen, Germany) and Dr. Brad Rovin (Ohio State University, United States) will co-chair this conference.

 

KDIGO makes preliminary Scope of Work documents available for public review prior to final planning of any Controversies Conference. We invite you to provide your on the Scope of Work which can be found in the Resources section. Kindly submit your comments via the form below no later than Monday, April 21.